Case report: Treatment of two cases of recurrent/refractory early T-cell precursor acute lymphoblastic leukemia with venetoclax combined with the CAG regimen.

MLA

Jiang, Yuxia, et al. “Case Report: Treatment of Two Cases of Recurrent/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia with Venetoclax Combined with the CAG Regimen.” Frontiers in Medicine, vol. 11, Mar. 2024, p. 1358161. EBSCOhost, https://doi.org/10.3389/fmed.2024.1358161.

APA

Jiang, Y., Ji, L., Jin, X., Wu, H., He, M., Shen, F., Xu, X., & Jiang, H. (2024). Case report: Treatment of two cases of recurrent/refractory early T-cell precursor acute lymphoblastic leukemia with venetoclax combined with the CAG regimen. Frontiers in Medicine, 11, 1358161. https://doi.org/10.3389/fmed.2024.1358161

Chicago

Jiang, Yuxia, Lin Ji, Xin Jin, Haiying Wu, Mingxia He, Fenglin Shen, Xiaofeng Xu, and Huifang Jiang. 2024. “Case Report: Treatment of Two Cases of Recurrent/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia with Venetoclax Combined with the CAG Regimen.” Frontiers in Medicine 11 (March): 1358161. doi:10.3389/fmed.2024.1358161.